ST. LOUIS–(BUSINESS WIRE)–PierianDx, the leading genomics technology company that enables precision medicine, announced today a full range of expanded services to support adoption of the company’s enterprise software platform, the Clinical Genomics WorkSpace (CGW).
“CGW’s end-to-end workflow and robust knowledgebase has been the backbone of that promise, and now our expanded Clinical Genomics Services doubles down on that mission.”
“Since PierianDx was first founded in 2014, our mission has always been to enable precision medicine for our customers,” said PierianDx founder and CEO Rakesh Nagarajan. “CGW’s end-to-end workflow and robust knowledgebase has been the backbone of that promise, and now our expanded Clinical Genomics Services doubles down on that mission.”
One component of PierianDx’s services encompasses preparing labs for precision medicine and expanded molecular testing, which includes planning with the clinical team, molecular tumor board development, physician engagement, and technology integration into legacy laboratory information management systems (LIMS) and electronic medical records (EMR).
The other component of PierianDx’s technology-enabled scientific and medical services is focused on the clinical lab, which includes services for assay validation, assay selection, and interpretation. PierianDx also offers turnkey and custom assays through its lab services, which is performed in a laboratory that has been accredited by the College of American Pathologists (CAP) and/or has Clinical Laboratory Improvement Amendments (CLIA) certification.
PierianDx’s Clinical Genomics Services team is comprised of more than 40 medical professionals, scientists, and bioinformatics experts delivering services across the spectrum of the molecular pathology lab workflow.
Nagarajan said the services expansion is part of PierianDx’s solution approach that recognizes customers have varying needs for accelerating their precision medicine programs.
“Most customers have their own in-house capabilities and simply need a trusted partner to ramp up their efforts,” Nagarajan explained. “CGW, our robust knowledgebase of shared interpretations, and our support services align seamlessly with a clinical lab’s workflow, transforming our technology platform into a true solution for our customers.”
About PierianDx
PierianDx is the leading genomics technology provider that enables precision medicine programs for healthcare organizations by offering solutions to accelerate molecular testing and results delivery. PierianDx does this by producing Actionable Intelligence™ through its workflow and analysis software, the Clinical Genomics WorkSpace™, that is driven by a constantly learning knowledgebase and deep clinical expertise. The resulting data visualization and easy-to-understand reports are used to deliver patient-specific diagnosis and treatments for somatic and inherited diseases based on an individual’s DNA and RNA. Since being founded by scientists, clinicians and bioinformatics experts in 2014, PierianDx has expanded its partner network to include leading health systems, academic medical centers, cancer centers, children’s hospitals, and commercial labs.
Please visit www.pieriandx.com or @PierianDx on Twitter.
